State Street Corp Kymera Therapeutics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,728,144 shares of KYMR stock, worth $72.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,728,144
Previous 1,910,691 9.55%
Holding current value
$72.5 Million
Previous $57 Million 43.41%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$30.16 - $52.4 $5.51 Million - $9.57 Million
-182,547 Reduced 9.55%
1,728,144 $81.8 Million
Q2 2024

Aug 14, 2024
SELL
$29.85 - $39.42 $22.7 Million - $30 Million
-761,827 Reduced 28.51%
1,910,691 $57 Million
Q1 2024

May 15, 2024
BUY
$22.9 - $43.57 $17.8 Million - $33.9 Million
778,239 Added 41.08%
2,672,518 $107 Million
Q4 2023

Feb 14, 2024
SELL
$10.97 - $26.84 $1 Million - $2.46 Million
-91,607 Reduced 4.61%
1,894,279 $48.2 Million
Q3 2023

Nov 14, 2023
SELL
$13.9 - $23.88 $8.82 Million - $15.2 Million
-634,423 Reduced 24.21%
1,985,886 $27.6 Million
Q2 2023

Aug 14, 2023
SELL
$22.4 - $34.92 $2.39 Million - $3.72 Million
-106,516 Reduced 3.91%
2,620,309 $60.2 Million
Q1 2023

May 15, 2023
SELL
$24.84 - $38.75 $2.97 Million - $4.63 Million
-119,396 Reduced 4.19%
2,726,825 $80.8 Million
Q4 2022

Feb 14, 2023
BUY
$19.57 - $30.92 $3.15 Million - $4.97 Million
160,817 Added 5.99%
2,846,221 $71 Million
Q3 2022

Nov 15, 2022
SELL
$20.91 - $34.27 $17.3 Million - $28.4 Million
-829,034 Reduced 23.59%
2,685,404 $58.5 Million
Q2 2022

Aug 15, 2022
BUY
$14.13 - $42.55 $20.1 Million - $60.4 Million
1,419,877 Added 67.79%
3,514,438 $69.2 Million
Q1 2022

May 16, 2022
BUY
$35.3 - $64.68 $16 Million - $29.3 Million
452,799 Added 27.58%
2,094,561 $88.6 Million
Q4 2021

Feb 14, 2022
BUY
$49.91 - $65.56 $10.1 Million - $13.2 Million
201,986 Added 14.03%
1,641,762 $104 Million
Q3 2021

Nov 15, 2021
BUY
$47.8 - $66.66 $4.93 Million - $6.87 Million
103,130 Added 7.72%
1,439,776 $84.6 Million
Q2 2021

Aug 16, 2021
BUY
$31.08 - $51.95 $12.4 Million - $20.8 Million
399,731 Added 42.66%
1,336,646 $64.8 Million
Q1 2021

May 17, 2021
BUY
$35.64 - $85.46 $27.7 Million - $66.3 Million
776,370 Added 483.58%
936,915 $36.4 Million
Q4 2020

Feb 16, 2021
BUY
$28.07 - $87.83 $4.51 Million - $14.1 Million
160,545 New
160,545 $9.95 Million

Others Institutions Holding KYMR

# of Institutions
184
Shares Held
64.4M
Call Options Held
50.6K
Put Options Held
81.7K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.3B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email